Zhai Z, Zhu ZY, Cong XL, Han BL, Gao JL, Yin X, Zhang Y, Lou SH, Fang TY, Wang YM, Li CF, Yu XF, Ma Y, Xue YW. Changing trends of clinicopathologic features and survival duration after surgery for gastric cancer in Northeast China. World J Gastrointest Oncol 2020; 12(10): 1119-1132 [PMID: 33133381 DOI: 10.4251/wjgo.v12.i10.1119]
Corresponding Author of This Article
Ying-Wei Xue, MD, Chief Doctor, Department of Gastroenterological Surgery, Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin 150081, Heilongjiang Province, China. xueyingwei@hrbmu.edu.cn
Research Domain of This Article
Oncology
Article-Type of This Article
Retrospective Cohort Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Oncol. Oct 15, 2020; 12(10): 1119-1132 Published online Oct 15, 2020. doi: 10.4251/wjgo.v12.i10.1119
Table 1 Treatments for all patients, n (%)
Surgical procedure
2000-2004 (n = 853)
2005-2009 (n = 1707)
2010-2014 (n = 3327)
2000-2014 (n = 5887)
Proximal gastrectomy
60 (7)
152 (8.9)
228 (6.9)
440 (7.5)
Subtotal distal gastrectomy
398 (46.7)
946 (55.4)
1646 (49.5)
2990 (50.8)
Total gastrectomy
189 (22.2)
354 (20.7)
771 (23.2)
1314 (22.3)
Palliative surgery
80 (9.4)
97 (5.7)
193 (5.8)
370 (6.3)
Exploratory laparotomy
23 (2.7)
45 (2.6)
200 (6)
268 (4.6)
No surgery
103 (12.1)
113 (6.6)
289 (8.7)
505 (8.6)
Table 2 Clinicopathological characteristics of gastric cancer patients at different time periods, n (%)
2000-2004 (n = 647)
2005-2009 (n = 1452)
2010-2014 (n = 2645)
2000-2014 (n = 4744)
P value
Gender
0.321
Male
462 (71.4)
1079 (74.3)
1961 (74.1)
3502 (73.8)
Female
185 (28.6)
373 (25.7)
684 (25.9)
1242 (26.2)
Age (yr)
0.000
≤ 45
110 (17)
177 (12.2)
286 (10.8)
573 (12.1)
45-65
362 (56)
822 (56.6)
1695 (64.1)
2879 (60.7)
> 65
175 (27)
453 (31.2)
664 (25.1)
1292 (27.2)
Tumor location
0.017
Upper third
74 (11.4)
158 (10.9)
336 (12.7)
568 (12)
Middle third
89 (13.8)
237 (16.3)
343 (13)
669 (14.1)
Lower third
373 (57.7)
836 (57.6)
1586 (60)
2795 (58.9)
Whole stomach
115 (17.8)
221 (15.2)
380 (14.3)
712 (15)
Tumor size (mm)
0.000
< 50
192 (29.7)
593 (40.8)
1105 (41.8)
1890 (39.8)
≥ 50
455 (70.3)
859 (59.2)
1540 (58.2)
2854 (60.2)
Histologic type
0.000
Well/moderately differentiated
184 (28.4)
492 (33.9)
1101 (41.6)
1777 (37.5)
Lowly/undifferentiated
463 (71.6)
960 (66.1)
1544 (58.4)
2967 (62.5)
T stage
0.000
T1
25 (3.9)
121 (8.3)
380 (14.4)
526 (11.1)
T2
112 (17.3)
197 (13.6)
258 (9.8)
567 (12)
T3
110 (17)
155 (10.7)
820 (31)
1085 (22.9)
T4
400 (61.8)
979 (67.4)
1187 (44.9)
2566 (54.1)
N stage
0.000
N0
226 (34.9)
493 (34)
999 (37.8)
1717 (36.2)
N1
195 (30.1)
285 (19.6)
407 (15.4)
888 (18.7)
N2
126 (19.5)
217 (14.9)
422 (16)
765 (16.1)
N3
100 (15.5)
457 (31.5)
817 (30.9)
1374 (29)
M stage
0.000
M0
572 (88.4)
1352 (93.1)
2484 (93.9)
4408 (92.9)
M1
75 (11.6)
100 (6.9)
161 (6.1)
336 (7.1)
TNM stage
0.000
I
65 (10)
184 (12.7)
468 (17.7)
717 (15.1)
II
167 (25.8)
360 (24.8)
587 (22.2)
1114 (23.5)
III
340 (52.6)
808 (55.6)
1429 (54)
2577 (54.3)
IV
75 (11.6)
100 (6.9)
161 (6.1)
336 (7.1)
Table 3 Surgical characteristics of patients with gastric cancer at different time periods, n (%)
2000-2004 (n = 647)
2005-2009 (n = 1452)
2010-2014 (n = 2645)
2000-2014 (n = 4744)
P value
Type of gastrectomy
0.010
Proximal gastrectomy
60 (9.3)
152 (10.5)
228 (8.6)
440 (9.3)
Subtotal distal gastrectomy
398 (61.5)
946 (65.2)
1646 (62.2)
2990 (63)
Total gastrectomy
189 (29.2)
354 (24.4)
771 (29.1)
1314 (27.7)
Local infiltration
0.014
Yes
100 (15.5)
268 (18.5)
538 (20.3)
906 (19.1)
No
547 (85.5)
1184 (81.5)
2107 (79.7)
3838 (80.9)
Margin status
0.050
R0
536 (82.8)
1139 (78.4)
2133 (80.6)
3808 (80.3)
R1/R2
111 (17.2)
313 (21.6)
512 (19.4)
936 (19.7)
Joint resection
0.000
Yes
59 (9.1)
36 (2.5)
106 (4)
201 (4.2)
no
588 (90.9)
1416 (97.5)
2539 (96)
4543 (95.8)
Early postoperative complications
0.000
Yes
24 (3.7)
20 (1.4)
141 (5.3)
185 (3.9)
No
623 (96.3)
1432 (98.6)
2504 (94.7)
4558 (96.1)
No. of retrieved lymph nodes
0.000
< 15
559 (86.4)
633 (43.6)
349 (13.2)
1541 (32.5)
15-30
81 (12.5)
678 (46.7)
1294 (48.9)
2053 (42.3)
≥ 30
7 (1.1)
141 (9.7)
1002 (37.9)
1150 (24.2)
Table 4 Univariate and multivariate analyses of prognostic factors in patients with gastric cancer
Factor
Univariate analysis
Multivariate analysis
HR
95%CI
P value
HR
95%CI
P value
Gender
1.026
0.944-1.114
0.547
-
-
-
Age (yr)
1.091
1.026-1.160
0.005
1.105
1.039-1.176
0.002
Tumor location
1.150
1.096-1.206
0.000
0.979
0.936-1.024
0.353
Tumor size (mm)
2.578
2.375-2.797
0.000
1.206
1.100-1.322
0.000
Histologic type
1.484
1.373-1.604
0.000
1.172
1.082-1.270
0.000
TNM stage
2.640
2.498-2.791
0.000
1.267
1.136-1.412
0.000
T stage
1.756
1.679-1.836
0.000
1.189
1.120-1.262
0.000
N stage
1.657
1.607-1.708
0.000
1.344
1.287-1.403
0.000
M stage
4.140
3.686-4.651
0.000
1.150
0.968-1.365
0.112
Type of gastrectomy
1.677
1.569-1.792
0.000
1.201
1.122-1.286
0.000
Local infiltration
0.320
0.295-0.347
0.000
0.662
0.602-0.727
0.000
Margin status
4.029
3.713-4.372
0.000
1.843
1.666-2.040
0.000
Joint resection
0.539
0.461-0.629
0.000
0.919
0.783-1.079
0.304
Early postoperative complications
0.975
0.808-1.177
0.794
-
-
-
No. of retrieved lymph nodes
0.872
0.830-0.916
0.000
0.847
0.796-0.901
0.000
Year group
0.774
0.737-0.813
0.000
0.859
0.808-0.913
0.000
Citation: Zhai Z, Zhu ZY, Cong XL, Han BL, Gao JL, Yin X, Zhang Y, Lou SH, Fang TY, Wang YM, Li CF, Yu XF, Ma Y, Xue YW. Changing trends of clinicopathologic features and survival duration after surgery for gastric cancer in Northeast China. World J Gastrointest Oncol 2020; 12(10): 1119-1132